4-[(4-fluoroanilino)methylidene]cyclohexa-2,5-dien-1-one

We are 4-[(4-fluoroanilino)methylidene]cyclohexa-2,5-dien-1-one CAS:3382-63-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-[(4-fluoroanilino)methylidene]cyclohexa-2,5-dien-1-one
CAS.NO:3382-63-6
Synonyms:4-[(4-fluoroanilino)methylidene]cyclohexa-2,5-dien-1-one
4-[[(p-Fluorophenyl)imino]methyl]phenol
4-[[(4-Fluorophenyl)imino]methyl]phenol
ALPHA-(4-FLUOROPHENYLIMINO)-P-CRESOL
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 370.9±27.0 °C at 760 mmHg
Molecular Formula C13H10FNO
Molecular Weight 215.223
Flash Point 178.1±23.7 °C
Vapour Pressure 0.0±0.9 mmHg at 25°C
Index of Refraction 1.558
 
Specification:
Appearance:Light yellow crystal
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ezetimibe(CAS:163222-33-1).

4-[(4-fluoroanilino)methylidene]cyclohexa-2,5-dien-1-one


Related News: Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.4-Ethylbenzoic acid CAS:619-64-7 Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.2',3',5'-Triacetyl -azacytidine China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.862273-27-6 China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.

Related Products
Product Name
L-Lysine Monohydrochloride View Details
2,6-dimethylaniline View Details
2-(2,5-Diaminophenyl)ethanol sulfate View Details
4-Bromophenylboronic acid manufacturer Diethanolamine manufacturer [2-Fluoro-4-(4-propylcyclohexyl)phenyl]boronic acid manufacturer 5-Bromo-2-chlorobenzaldehyde manufacturer Tetraethylammonium bromide manufacturer